Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ClouDr GroupFRA:H3L 48 Days Payable is 81.04 as of Dec. 2025, which is 183% above its 10-year median of 28.68. GuruFocus rates FRA:H3L with a GF Score™ of 48/100 and a GF Value™ of €0.08. The stock has 9 warning signs investors should review. Among 117 Medical Distribution companies, ClouDr Group ranks worse than 64.96% on this metric.
The historical data trend for ClouDr Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, ClouDr Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ClouDr Group Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ClouDr Group's Days Payable distribution charts can be found below:
* The bar in red indicates where ClouDr Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
ClouDr Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ClouDr Group (FRA:H3L) has a Days Payable of 81.04 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ClouDr Group and its competitors. This is 183% above median its historical median of 28.68. Over the past decade, ClouDr Group's Days Payable has ranged from 16.21 to 64.01. According to the industry distribution chart, ClouDr Group ranks #76 out of 117 companies in the Medical Distribution industry, placing it in the top 65%.
Is ClouDr Group's Days Payable too high?
ClouDr Group's current Days Payable of 81.04 is 183% above median its 10-year median of 28.68. Over the past 10 years, this metric has ranged from a low of 16.21 to a high of 64.01. The Medical Distribution industry median Days Payable is 76.68. ClouDr Group's value of 81.04 is 5.7% above this industry median. Based on the distribution chart, ClouDr Group ranks #76 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, ClouDr Group has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does ClouDr Group's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ClouDr Group ranks #76 out of 117 companies for Days Payable. This places ClouDr Group in the lower half of its industry. The industry median Days Payable is 76.68. ClouDr Group's value of 81.04 is 5.7% above this benchmark. Historically, ClouDr Group's own Days Payable has ranged from 16.21 to 64.01 over the past decade. While the company's 10-year median is 28.68 vs. the industry median of 76.68, ClouDr Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 76.68, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ClouDr Group's current Days Payable of 81.04 is 5.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ClouDr Group and its competitors. For the Medical Distribution industry, the median Days Payable is 76.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ClouDr Group's current Days Payable is 81.04, which is 183% above median its own 10-year median of 28.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ClouDr Group stock overvalued right now?
ClouDr Group (FRA:H3L) has a current Days Payable of 81.04. The stock's GF Value™ is €0.08, compared to a current price of €0.05 — trading 36.9% below its estimated fair value. The current Days Payable is 81.04, which is 183% above median its 10-year median of 28.68 and 5.7% above the Medical Distribution industry median of 76.68. ClouDr Group's overall GF Score™ is 48/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For ClouDr Group (FRA:H3L), the current Days Payable is 81.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ClouDr Group (FRA:H3L) Overvalued in 2026?
Based on GuruFocus' analysis, ClouDr Group stock appears to be undervalued.
The current stock price of €0.05 is trading 36.9% below its estimated GF Value™ of €0.08.
Key valuation signals for FRA:H3L:
Days Payable: 81.04 (183% above median its 10-year median of 28.68)
GF Value™: €0.08 vs. price of €0.05 (36.9% below fair value)
Industry Position: 5.7% above the Medical Distribution median (#76 of 117)
No single metric tells the full story. See the FRA:H3L stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company's in-hospital solution consists of sales of medical devices, consumables, and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and the out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through the AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
48GF Score
Get the complete analysis for FRA:H3L
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:H3L has been successfully added to your 
